Multiple Sclerosis Lesions Linked to Depression
Researchers found multiple sclerosis lesions that were consistent with a previously discovered depression circuit, linking the conditions.
Researchers found multiple sclerosis lesions that were consistent with a previously discovered depression circuit, linking the conditions.
Verana Health is developing Qdata MS, a Neurology Qdata module to help advance research and develop strategies for treating MS patients.
Researchers have developed a model that can predict how stay-at-home orders affect the mental health of people with neurological disorders.
Helius Medical Technologies Inc, a neurotech company, reports financial results for the quarter that ended June 30, 2022.
Read MoreA MedUni Vienna study suggests that the retina can be used as a prognostic marker to predicts the severity of future MS relapses.
Read MoreFor people with multiple sclerosis, there are specific factors that may affect a person’s physical and mental quality of life.
Read MoreMultiple sclerosis patients receiving anti-CD20 therapy saw strong T-cell activation after receiving two doses of the COVID-19 vaccine.
Read MoreMymee has acquired Berlin-based Breakthrough Health, the creator of the mobile app Emilyn for people with multiple sclerosis (MS).
Read MoreVia the FENhance study, AHN doctors are exploring the use of a new drug to treat relapsing or primary progressive multiple sclerosis.
Read MoreExperts encourage ongoing investigation of the benefits of exercise for people with multiple sclerosis, citing shortcomings of other studies.
Read MoreRune Labs is enrolling patients with multiple sclerosis in a study to identify neurophysiological biomarkers of the disease.
Read MorePoNS Therapy training for physical therapists treating patients with multiple sclerosis is now available on demand from Helius.
Read MoreVirtual reality may increase the effectiveness of cognitive rehabilitation and exercise training in individuals with MS, per Kessler.
Read MoreOM1 publishes its validation of a machine learning approach to estimate expanded disability status scale scores for multiple sclerosis.
Read MoreBiogen and Happify Health announce a collaboration to provide an AI-powered education and engagement solution for people living with MS.
Read MoreEkso Bionics has received 510(k) clearance from the FDA to market its EksoNR robotic exoskeleton for use with multiple sclerosis patients.
Read MoreFind Therapeutics Inc and SATT Conectus have signed a license to develop a therapy for Multiple Sclerosis and Optic Neuritis.
Read MoreNeurologyLive and the Consortium of Multiple Sclerosis Centers (CMSC) announce the inaugural class of Giants of Multiple Sclerosis inductees.
Read More